青少年有限制性饮食障碍的肝功能测试和全血计:有什么区别?
Hanna Suh1, Lise DeShea2, Briana Griffin2
1Case Western Reserve University School of Medicine, Cleveland, Ohio.
概括
神经性厌食症 (AN) 和避免/限制性食物摄入障碍 (ARFID) 显示出明显的肝功能和血液细胞计差异,即使在相似的BMI. 需要进一步研究饮食摄入量,以了解这些实验室变异.
科学领域:
- 儿科胃肠病学 儿科胃肠病学
- 临床营养学 临床营养学
- 血液学 血液学 血液学
背景情况:
- 神经性厌食症 (AN) 与异常的肝功能测试 (LFTs) 和血液学参数有关.
- 避免/限制性食物摄入障碍 (ARFID) 与这些实验室值之间的关联不太清楚.
- 这项研究调查了青少年在AN和ARFID之间LFT和全血细胞计 (CBC) 的差异.
研究的目的:
- 探索AN与ARFID诊断之间的关联,以及特定的肝功能测试和全血计数.
- 为了比较被诊断患有AN和ARFID的青少年患者之间的实验室发现.
主要方法:
- 对青少年患者 (2013-2023) 在饮食失调计划中的数据的回顾性分析.
- 检查了肝酶 (阿兰氨基转移酶,酸氨基转移酶,脂酶),CBC (血红蛋白,血小板计数,白细胞计数) 和诊断类别之间的关联.
- 统计分析包括千平方测试,通用线性模型和后勤回归,控制BMI,年龄,疾病持续时间和食物摄入量.
主要成果:
- 患有AN (n=123) 和ARFID (n=100) 的患者表现出相似的年龄%的BMI中位数.
- 与ARFID患者相比,AN患者的平均氨酸氨基转移酶水平显著更高.
- ARFID患者的平均白细胞和血小板数量明显高于AN患者,与更高的卡路里密度食物摄入量相关.
结论:
- 在具有可比性BMI的AN和ARFID患者之间存在氨酸氨基转移酶,白细胞和血小板计数的显著差异.
- 这些发现突出了这些饮食障碍的独特血液学和肝脏特征.
- 建议进一步研究宏观营养素摄入量,以阐明这些实验室差异背后的机制.
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
185
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
185
Anorexia Nervosa
1.0K
Anorexia nervosa is a complex and severe eating disorder characterized by an intense fear of weight gain, an unrelenting pursuit of thinness, and a distorted body image. It often leads to dangerously low body weight relative to an individual's age and height. This disorder is marked by significant physical and psychological consequences, making it one of the most life-threatening psychiatric illnesses.
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
Symptoms and Physical Effects
Individuals with anorexia nervosa commonly exhibit extreme...
1.0K
Hepatic Drug Clearance: Restrictive and Nonrestrictive Clearance
479
Hepatic clearance refers to the volume of blood cleared of a drug by the liver per unit of time. It plays a crucial role in drug metabolism and elimination. While hepatic clearance is commonly estimated by subtracting renal clearance from total body clearance, other pathways, such as pulmonary or biliary clearance, may also contribute. However, these pathways are generally less significant than hepatic and renal clearance.
Most drugs undergo restrictive clearance, which is proportional to the...
Most drugs undergo restrictive clearance, which is proportional to the...
479
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
215
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
215
Bulimia Nervosa
692
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
692
Bioavailability Study Design: Healthy Subjects Versus Patients
144
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
144


